HTGC · Business Development Company
Hercules Capital Inc
Private credit portfolio and Schedule of Investments data from SEC EDGAR filings.
390
Portfolio Holdings
$5.6B
Total Fair Value
Filing Information
Top Portfolio Holdings
| Company | Sector | Investment | Coupon | Maturity | Cost | Fair Value |
|---|---|---|---|---|---|---|
| 23andMe, Inc. | Equity | $5,094 | — | |||
| 3GTMS, LLC | Equity | $1,000 | — | |||
| 3GTMS, LLC | Senior Secured | 3-month SOFR + 10.40%, Floor rate 11.30% | February 2025 | $13,268 | — | |
| 908 Devices, Inc. | Warrant | $101 | — | |||
| ATAI Life Sciences N.V. | Senior Secured | Prime + 4.30%, Floor rate 9.05%, 6.95% Exit Fee | August 2026 | $14,442 | — | |
| Achronix Semiconductor Corporation | Equity | $160 | — | |||
| Achronix Semiconductor Corporation | Warrant | $92 | — |
Note: 18 rows hidden pending re-parse of HTGC's Schedule of Investments. Visible rows are validated.
About Hercules Capital Inc
Hercules Capital Inc (HTGC) is a publicly traded Business Development Company (BDC) — essentially a publicly listed fund that lends money to mid-sized private companies. In plain English: BDCs raise money from public investors and lend it to businesses that are too small for Wall Street banks. By law, they must pay out at least 90% of their profits as dividends, which is why BDC yields are often 8–12%. Hercules Capital Inc discloses its full loan portfolio through SEC filings.